APA

Dharamsi J. W., Bhosle M., Balkrishnan R., Yentzer B. A. & Feldman S. R. (20100201). Using 'number needed to treat' to help conceptualize the magnitude of benefit and risk of tumour necrosis factor-alpha inhibitors for patients with severe psoriasis. : The British journal of dermatology.

Chicago

Dharamsi J W, Bhosle M, Balkrishnan R, Yentzer B A and Feldman S R. 20100201. Using 'number needed to treat' to help conceptualize the magnitude of benefit and risk of tumour necrosis factor-alpha inhibitors for patients with severe psoriasis. : The British journal of dermatology.

Harvard

Dharamsi J. W., Bhosle M., Balkrishnan R., Yentzer B. A. and Feldman S. R. (20100201). Using 'number needed to treat' to help conceptualize the magnitude of benefit and risk of tumour necrosis factor-alpha inhibitors for patients with severe psoriasis. : The British journal of dermatology.

MLA

Dharamsi J W, Bhosle M, Balkrishnan R, Yentzer B A and Feldman S R. Using 'number needed to treat' to help conceptualize the magnitude of benefit and risk of tumour necrosis factor-alpha inhibitors for patients with severe psoriasis. : The British journal of dermatology. 20100201.